Speech-Language Pathologists in Toa Alta, PR Accepting Medicare

9 Speech-Language Pathologists found. Showing 1 - 9

Marilyan Ducos Rosario Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1164 Calle Finlandia, Toa Alta, PR 00953 Phone: 787-662-6112

Cristina Lee Correa Sierra, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Brisas De Montecasino 549, Toa Alta, PR 00953 Phone: 939-640-3036

Mrs. Idalis Lopez Ramos, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1162 Calle Finlandia, Plaza De Las Fuentes, Toa Alta, PR 00953 Phone: 787-648-9596

Franshesca Santiago Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Urb Praderas Del Rio, 252 Calle Monte Escarcha, Toa Alta, PR 00953 Phone: 787-550-2653

Mrs. Beggy Liz Santiago-mercado, PHL Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 278 Lope De Vega, Toa Alta, PR 00953 Phone: 787-223-7964

Miss Geraldine Morla Soto, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 23 Calle Ucar, Cuidad Jardin Iii, Toa Alta, PR 00953 Phone: 939-244-7076

Mrs. Jidaliz Adorno Alicea, M.S.SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Rr 2 Box 2006, Toa Alta, PR 00953 Phone: 787-414-3507

Ibbis Rivera Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: R38 Calle 22, Toa Alta Heights, Toa Alta, PR 00953 Phone: 787-327-2772

Joy Therapy Group, Llc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Calle Taino K-15, Toa Alta, PR 00953 Phone: 939-640-3036

News Archive

LDTD Technology at BASi increases speed of sample analysis

BASi provides clients with increased sample analysis speed and quick turnaround with the LDTD technology. Fast screening is combined with accurate quantification results, to benefit any bioanalytical studies.

PositiveID, Receptors announce milestone in development of in vivo glucose-sensing RFID microchip

PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that the companies have achieved a milestone in the development of their in vivo glucose-sensing RFID microchip to detect glucose levels in the body. The companies have completed the synthesis of a new chemical building block that will serve as the anchor of their next generation of Combinatorial Artificial Receptor (CARA™) surfaces for the sensing system component of the implantable glucose sensor.

Halozyme Therapeutics receives FDA clearance for Cumulase

Halozyme Therapeutics has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Cumulase for the treatment of oocytes to facilitate certain in vitro fertilization (IVF) procedures. The active pharmaceutical ingredient in Cumulase is the first and only recombinant human hyaluronidase approved in the United States for cumulus removal in the IVF process.

NHS Breast Screening Programme detects 1,500 invasive cancers

A new report has revealed that the NHS Breast Screening Programme detected nearly 1,500 cases of the disease in 2008-09 in Scotland.Since 1991, the programme has screened over 2.3 million women in Scotland and has led to the diagnosis of approximately 17,000 breast cancers.The latest statistics, which are published by ISD Scotland, show that about three-quarters of women who were invited to attend screening in 2008-09 accepted their invitation.

China PharmaHub announces new joint venture for humanized antibody

China PharmaHub Corp., announced today that it has entered into a definitive agreement with Dr. David Weaver and Dr. Michael Rynkiewicz. In addition, PharmaHub contemplates merging with World Wide Relics, Inc. of which it recently purchased a 77% interest.

Read more Medical News

› Verified 5 days ago